SGA
COGT icon

Sector Gamma AS’s Cogent Biosciences COGT Stock Holding History

Sector Gamma AS’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.08M Buy
+80,000
New +$2.95M 0.73% 40

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Sector Gamma AS's COGT Position: Q1 2026 in Review

Sector Gamma AS opened a new position in Cogent Biosciences (COGT) in Q1 2026: 80,000 shares worth $3.08M. The stake represents 0.73% of the portfolio and ranks #40 among its holdings.

305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Sector Gamma AS held 80,000 shares of Cogent Biosciences worth $3.08M as of Q1 2026.
  • Cogent Biosciences was a new Sector Gamma AS position in Q1 2026.
  • Cogent Biosciences made up 0.73% of Sector Gamma AS's portfolio in Q1 2026, its #40 holding.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.